Items where authors include "Bottomley, D"

Article

Payne, H, Bomanji, J, Bottomley, D et al. (3 more authors) (2022) Impact of 18F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical prostatectomy. Nuclear Medicine Communications, 43 (2). pp. 201-211. ISSN 0143-3636

Young, C orcid.org/0000-0001-5709-4413, Wood, HM orcid.org/0000-0003-3009-5904, Fuentes Balaguer, A et al. (13 more authors) (2021) Microbiome Analysis of More Than 2,000 NHS Bowel Cancer Screening Programme Samples Shows the Potential to Improve Screening Accuracy. Clinical Cancer Research, 27 (8). pp. 2246-2254. ISSN 1078-0432

Dunwell, TL, Dailey, SC, Ottestad, AL et al. (13 more authors) (2021) Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNA. Scientific Reports, 11. 3138. ISSN 2045-2322

Slevin, F, Sethugavalar, B, Al-Qaisieh, B et al. (5 more authors) (2020) Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancer. Journal of Contemporary Brachytherapy, 12 (6). pp. 540-546. ISSN 1689-832X

Slevin, F, Rodda, SL, Bownes, P et al. (10 more authors) (2020) Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’. Clinical and Translational Radiation Oncology, 24. p. 52. ISSN 2405-6308

Slevin, F, Hodgson, S, Rodda, SL et al. (9 more authors) (2020) Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer. Clinical and Translational Radiation Oncology, 23. pp. 20-26. ISSN 2405-6308

Slevin, F, Rodda, SL, Bownes, P et al. (10 more authors) (2020) A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy. Clinical and Translational Radiation Oncology, 20. pp. 1-8. ISSN 2405-6308

Yoshikawa, T, Aoyama, T, Sakamaki, K et al. (19 more authors) (2019) Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer. Journal of Cancer, 10 (21). pp. 5130-5138. ISSN 1837-9664

Parikh, S, Murray, L orcid.org/0000-0003-0658-6455, Kenning, L et al. (10 more authors) (2018) Real-world Outcomes and Factors Predicting Survival and Completion of Radium 223 in Metastatic Castrate-resistant Prostate Cancer. Clinical Oncology, 30 (9). pp. 548-555. ISSN 0936-6555

Frood, R, Baren, J, McDermott, G et al. (3 more authors) (2018) Diagnostic performance of a streamlined 18 F-choline PET-CT protocol for the detection of prostate carcinoma recurrence in combination with appropriate-use criteria. Clinical Radiology, 73 (7). pp. 632-639. ISSN 0009-9260

Binzel, K, Adelaja, A, Wright, CL et al. (202 more authors) (2018) Abstracts of the 33rd International Austrian Winter Symposium : Zell am See, Austria. 24-27 January 2018. EJNMMI Research, 8 (Suppl 1). 5. ISSN 2191-219X

Silva, ANS, Coffa, J, Menon, V et al. (19 more authors) (2018) Frequent Coamplification of Receptor Tyrosine Kinase and Downstream Signaling Genes in Japanese Primary Gastric Cancer and Conversion in Matched Lymph Node Metastasis. Annals of Surgery, 267 (1). pp. 114-121. ISSN 0003-4932

Gollins, S, West, N orcid.org/0000-0002-0346-6709, Sebag-Montefiore, D et al. (17 more authors) (2017) Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations. British Journal of Cancer, 117. pp. 1286-1294. ISSN 0007-0920

Henry, AM, Rodda, SL, Mason, M et al. (7 more authors) (2015) The Effect of Dose and Quality Assurance in Early Prostate Cancer Treated with Low Dose Rate Brachytherapy as Monotherapy. Clinical Oncology, 27 (7). 382 - 386. ISSN 0936-6555

van Grieken, NCT, Aoyama, T, Chambers, PA orcid.org/0000-0002-0926-717X et al. (19 more authors) (2013) KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: Results from a large international multicentre study. British Journal of Cancer, 108 (7). pp. 1495-1501. ISSN 0007-0920

Conference or Workshop Item

West, NP, Kodavatiganti, R, Hemmings, G et al. (6 more authors) (2015) Pre-Treatment and Post-Treatment Epidermal Growth Factor Receptor Pathway Mutations in a Prospective Phase II Trial (NWCOG EXCITE) of Cetuximab-Containing Chemoradiation in Locally Advanced Rectal Cancer. In: Dublin Pathology 2015: 8th Joint Meeting of the British Division of the International Academy of Pathologyand the Pathological Society of Great Britain & Ireland, 23-25 Jun 2015, Dublin.

Proceedings Paper

Bottomley, D, Scarsbrook, A orcid.org/0000-0002-4243-032X, Teoh, EJ et al. (11 more authors) (2019) Impact of Positron Emission Tomography (PET) with 18F-Fluciclovine on Management of Patients with Recurrence of Prostate Cancer: Results from the Falcon Trial. In: Proceedings of the Amercian Society for Radiation Oncology 61st Annual Meeting. The Amercian Society for Radiation Oncology 61st Annual Meeting, 15-18 Sep 2019, Chicago, IL, USA. Elsevier , S136-S137.

Murakami, K, West, NP orcid.org/0000-0002-0346-6709, Westwood, AC et al. (10 more authors) (2019) The Relationship Between DNA Mismatch Repair and Response to FOLFOX-based Pre-operative Chemotherapy in the International Phase III FOxTROT Trial. In: Journal of Pathology. Leeds Pathology 2019. 12th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 02-04 Jul 2019, Leeds. Wiley , S17-S17.

Westwood, AC, Hemmings, GJ, Bottomley, D et al. (7 more authors) (2018) Comparison of Mismatch Repair Protein Expression Between Biopsies and Resections in Advanced Colon Cancer from the Phase II Group of the Fluoropyrimidine Oxaliplatin and Targeted Receptor Pre-Operative Therapy (FOxTROT) Trial. In: Journal of Pathology. Maastricht Pathology 2018. 11th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 19-22 Jun 2018, Maastricht. Wiley , S26-S26.

Westwood, AC, Bottomley, D, Hemmings, GJ et al. (11 more authors) (2018) Comparison of Mutational Status in the EGFR Pathway Across Four Different Platforms in the Fluoropyrimidine Oxaliplatin and Targeted Receptor Pre-Operative Therapy (FOxTROT) Trial. In: Journal of Pathology. Maastricht Pathology 2018. 11th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 19-22 Jun 2018, Maastricht. Wiley , S15-S15.

Teoh, E, Bottomley, D, Scarsbrook, A orcid.org/0000-0002-4243-032X et al. (15 more authors) (2017) Impact of F-18-fluciclovine PET/CT on Clinical Management of Patients with Recurrent Prostate Cancer: Results from the Phase 3 FALCON Trial. In: International Journal of Radiation Oncology Biology Physics. 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), 24-27 Sep 2017, San Diego, CA, USA. Elsevier , pp. 1316-1317.

Rodda, S, Sun, F, Henry, A orcid.org/0000-0002-5379-6618 et al. (2 more authors) (2016) EP-1337: PSA Kinetics: HDR prostate brachytherapy boost in combination with external beam radiotherapy. In: Radiotherapy and Oncology. ESTRO 35, 29 Apr - 03 May 2016, Turin, Italy. Elsevier , S625.

Sutton, KM, Bottomley, D, Morton, D et al. (2 more authors) (2015) Comparison of Histologically Normal Mucosa and Blood as Controls for Targeted Next Generation Sequencing Analysis in Patients with Colon Cancer in the NCRI FOxTROT Trial. In: Journal of Pathology. Dublin Pathology 2015: 8th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 23-25 Jun 2015, Dublin, Ireland. Wiley , S15-S15.

Taylor, M, Wood, H, Bottomley, D et al. (9 more authors) (2015) Comparison of Mutational Calls Obtained with Pyrosequencing and the Affymetrix OncoScan (R) FFPE Assay in Patients with Colon Cancer Recruited to the NCRI FOxTROT Trial. In: Journal of Pathology. Dublin Pathology 2015: 8th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 23-25 Jun 2015, Dublin, Ireland. Wiley , S39-S39.